UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

EXECUTIVE Safety Responsibility

Professional safety, 2023-10, Vol.68 (10), p.21-31

Schorn, Theodore J

2023

Volltextzugriff (PDF)

Branch Out to Prevent Failures in the Field

Modern Casting, 2014-09, Vol.104 (9), p.34-39

Schorn, Theodore J

2014

Volltextzugriff (PDF)

Branch out to prevent failures in the field: resolve warranty risk through fault tree analysis

Modern casting, 2014-09, Vol.104 (9), p.34

Schorn, Theodore J

2014

Volltextzugriff (PDF)

In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia

Journal of medicinal chemistry, 2000-07, Vol.43 (14), p.2703-2718

2000

Volltextzugriff (PDF)

Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones

Journal of medicinal chemistry, 1999-11, Vol.42 (23), p.4764-4777

1999

Volltextzugriff (PDF)

Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety

Journal of medicinal chemistry, 1999-11, Vol.42 (23), p.4778-4793

1999

Volltextzugriff (PDF)

De Novo Design of a Novel Oxazolidinone Analogue as a Potent and Selective α1A Adrenergic Receptor Antagonist with High Oral Bioavailability

Journal of medicinal chemistry, 2000-07, Vol.43 (15), p.2775-2778

2000

Volltextzugriff (PDF)

Design and Synthesis of Novel α1a Adrenoceptor-Selective Dihydropyridine Antagonists for the Treatment of Benign Prostatic Hyperplasia

Journal of medicinal chemistry, 1998-12, Vol.41 (26), p.5320-5333

1998

Volltextzugriff (PDF)

A highly potent, orally active imidazo-[4,5-b]pyridine biphenylacylsulfonamide (MK-996;L-159,282) : a new AT1-selective angiotensin II receptor antagonist

Journal of medicinal chemistry, 1994-11, Vol.37 (24), p.4068-4072

1994

Volltextzugriff (PDF)

Design and Synthesis of Novel α1 a Adrenoceptor-Selective Antagonists. 1. Structure−Activity Relationship in Dihydropyrimidinones

Journal of medicinal chemistry, 1999-11, Vol.42 (23), p.4764-4777

1999

Volltextzugriff (PDF)

Design and synthesis of N-alkylated saccharins as selective α-1a adrenergic receptor antagonists

Bioorganic & medicinal chemistry letters, 1998-09, Vol.8 (18), p.2467-2472

1998

Volltextzugriff (PDF)

In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996

American journal of hypertension, 1995-01, Vol.8 (1), p.58-66

1995

Volltextzugriff (PDF)

De Novo Design of a Novel Oxazolidinone Analogue as a Potent and Selective α 1A Adrenergic Receptor Antagonist with High Oral Bioavailability

Journal of medicinal chemistry, 2000-07, Vol.43 (15), p.2775-2778

2000

Volltextzugriff (PDF)

In vivo pharmacology of a novel AT 1 selective angiotensin II receptor antagonist, MK-996

American journal of hypertension, 1995, Vol.8 (1), p.58-66

1995

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)
Japanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Journal Of Medicinal Chemistry
(10)
American Journal Of Hypertension
(2)
Modern Casting
(2)
Bioorganic & Medicinal Chemistry Letters
(1)
Professional Safety
(1)

Menü

Weitere Dienste

Einstellungen

EXECUTIVE Safety Responsibility

Branch Out to Prevent Failures in the Field

Branch out to prevent failures in the field: resolve warranty risk through fault tree analysis

In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia

Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones

Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety

De Novo Design of a Novel Oxazolidinone Analogue as a Potent and Selective α1A Adrenergic Receptor Antagonist with High Oral Bioavailability

Design and Synthesis of Novel α1a Adrenoceptor-Selective Dihydropyridine Antagonists for the Treatment of Benign Prostatic Hyperplasia

A highly potent, orally active imidazo-[4,5-b]pyridine biphenylacylsulfonamide (MK-996;L-159,282) : a new AT1-selective angiotensin II receptor antagonist

Design and Synthesis of Novel α1 a Adrenoceptor-Selective Antagonists. 2. Approaches To Eliminate Opioid Agonist Metabolites via Modification of Linker and 4-Methoxycarbonyl-4-phenylpiperidine Moiety

Design and Synthesis of Novel α1 a Adrenoceptor-Selective Antagonists. 1. Structure−Activity Relationship in Dihydropyrimidinones

Design and synthesis of N-alkylated saccharins as selective α-1a adrenergic receptor antagonists

In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996

De Novo Design of a Novel Oxazolidinone Analogue as a Potent and Selective α 1A Adrenergic Receptor Antagonist with High Oral Bioavailability

Design and Synthesis of Novel α 1 a Adrenoceptor-Selective Antagonists. 2. Approaches To Eliminate Opioid Agonist Metabolites via Modification of Linker and 4-Methoxycarbonyl-4-phenylpiperidine Moiety

In vivo pharmacology of a novel AT 1 selective angiotensin II receptor antagonist, MK-996

Suchergebnisse filtern